From manufacturer to transformer:

As the pharmaceutical industry faces increasing innovation and digitalization pressure for more efficient R&D, manufacturing and QC processes, lab environments are evolving rapidly. This whitepaper explores how advanced laboratory technology can support pharmaceutical companies to drive significant productivity gains by digitalizing lab infrastructures, automating workflows and harmonizing data, ultimately enhancing research and quality control processes.

For manufacturers of lab devices and systems, transitioning from providing traditional, isolated hardware solutions to offering integrated, automated systems presents a unique opportunity to position themselves as innovative, customer oriented, and digital-, data- and automation-first players. By embracing digitalization, manufacturers can not only improve their product offerings but also create new revenue models that cater to the evolving needs of their customers¹.

Discover expert insights on the following topics in our whitepaper:

• What are the requirements for modern lab devices and systems in the context of digitalized and automated labs?
• How can manufacturers meet evolving customer needs in a rapidly changing environments?
• What are the key obstacles faced by labtech companies on their digitalization journeys?
• What strategies are currently being employed to navigate the complexities of digital transformation?
• How can labtech manufacturers empower their customers to create data-driven labs that enhance reliability and compliance?